OUR PRODUCTS

MOBILE APPS

GENERAL INFO

BHVN

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

Biohaven (BHVN) Earnings Date & Reports

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

BHVN is expected to report earnings to rise 16.56% to -189 cents per share on November 18

Q3'25

Est.

$-1.90

Q2'25

Beat

by $0.31

Q1'25

Missed

by $0.47

Q4'24

Missed

by $0.11

Q3'24

Missed

by $0.04

The last earnings report on August 11 showed earnings per share of -162 cents, beating the estimate of -194 cents. With 718.88K shares outstanding, the current market capitalization sits at 1.37B.

View a ticker or compare two or three

Compare

BHVN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For BHVN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BHVN showed earnings on August 11, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of pharmaceutical drugs

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Major

Address

215 Church Street

Phone

+1 203 404-0410

Employees

239

Web

https://www.biohavenpharma.com